Literature DB >> 11489928

Statins' benefits begin to sprout.

D C Altieri1.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11489928      PMCID: PMC209366          DOI: 10.1172/JCI13556

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  9 in total

Review 1.  Can modulation of endothelial nitric oxide synthase explain the vasculoprotective actions of statins?

Authors:  W C Sessa
Journal:  Trends Mol Med       Date:  2001-05       Impact factor: 11.951

2.  HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells.

Authors:  J Llevadot; S Murasawa; Y Kureishi; S Uchida; H Masuda; A Kawamoto; K Walsh; J M Isner; T Asahara
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

3.  Structural mechanism for statin inhibition of HMG-CoA reductase.

Authors:  E S Istvan; J Deisenhofer
Journal:  Science       Date:  2001-05-11       Impact factor: 47.728

4.  Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

Authors:  P Carmeliet; L Moons; A Luttun; V Vincenti; V Compernolle; M De Mol; Y Wu; F Bono; L Devy; H Beck; D Scholz; T Acker; T DiPalma; M Dewerchin; A Noel; I Stalmans; A Barra; S Blacher; T VandenDriessche; A Ponten; U Eriksson; K H Plate; J M Foidart; W Schaper; D S Charnock-Jones; D J Hicklin; J M Herbert; D Collen; M G Persico
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

5.  Lipid-lowering therapy in low-risk patients.

Authors:  T A Pearson
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

6.  HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.

Authors:  S Dimmeler; A Aicher; M Vasa; C Mildner-Rihm; K Adler; M Tiemann; H Rütten; S Fichtlscherer; H Martin; A M Zeiher
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 7.  What do the statin trials tell us?

Authors:  D D Waters
Journal:  Am J Manag Care       Date:  2001-05       Impact factor: 2.229

Review 8.  Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization.

Authors:  P Libby
Journal:  Am J Cardiol       Date:  2000-10-19       Impact factor: 2.778

Review 9.  Relation between endothelial dysfunction and the acute coronary syndrome: implications for therapy.

Authors:  S Kinlay; P Ganz
Journal:  Am J Cardiol       Date:  2000-10-19       Impact factor: 2.778

  9 in total
  3 in total

1.  Atorvastatin accelerates extracellular nucleotide degradation in human endothelial cells.

Authors:  Lana Osman; Mohamed Amrani; Charles Ilsley; Magdi H Yacoub; Ryszard T Smolenski
Journal:  Mol Cell Biochem       Date:  2007-12-25       Impact factor: 3.396

2.  Does simvastatin stimulate bone formation in vivo?

Authors:  Dietrich von Stechow; Susan Fish; Dror Yahalom; Itai Bab; Michael Chorev; Ralph Müller; Joseph M Alexander
Journal:  BMC Musculoskelet Disord       Date:  2003-04-28       Impact factor: 2.362

3.  Preventive effect of fluvastatin on the development of medication-related osteonecrosis of the jaw.

Authors:  Naomi Adachi; Yasunori Ayukawa; Noriyuki Yasunami; Akihiro Furuhashi; Mikio Imai; Koma Sanda; Ikiru Atsuta; Kiyoshi Koyano
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.